Cargando…

Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials

BACKGROUND: Isoflavone from soy and other plants modulate hormonal effects in women, and the hormone disorder might result in different caners including endometrial cancer. However, it's effect on the risk of endometrial cancer is still inconclusive. We aimed to assess the effects of isoflavone...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jie, Yuan, Feixiang, Gao, Jian, Shan, Boer, Ren, Yulan, Wang, Huaying, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951218/
https://www.ncbi.nlm.nih.gov/pubmed/26967050
http://dx.doi.org/10.18632/oncotarget.7959
_version_ 1782443660644712448
author Liu, Jie
Yuan, Feixiang
Gao, Jian
Shan, Boer
Ren, Yulan
Wang, Huaying
Gao, Ying
author_facet Liu, Jie
Yuan, Feixiang
Gao, Jian
Shan, Boer
Ren, Yulan
Wang, Huaying
Gao, Ying
author_sort Liu, Jie
collection PubMed
description BACKGROUND: Isoflavone from soy and other plants modulate hormonal effects in women, and the hormone disorder might result in different caners including endometrial cancer. However, it's effect on the risk of endometrial cancer is still inconclusive. We aimed to assess the effects of isoflavone on endometrial thickness, a risk factor of endometrial cancer in peri- and post-menopausal women. METHODS: A meta-analysis of randomized controlled trials was conducted to evaluate the effect of oral isoflavone supplementation on endometrial thickness in peri- and post-menopausal women. Electronic searches were performed on the PubMed, Embase, the Cochrane Library, web of science, CINAHL, and WHO ICTRP to August 1(st), 2015. Reviews and reference lists of relevant articles were also searched to identify more studies. Summary estimates of standard mean differences (SMD's) and 95%CIs were obtained with random-effects models. Heterogeneity was evaluated with meta-regression and stratified analyses. RESULTS: A total of 23 trials were included in the current analysis. The overall results did not show significant change of endometrial thickness after oral isoflavone supplementation (23 studies, 2167subjects; SMD:-0.05; 95%CI:-0.23, 0.13; P=0.60). Stratified analysis suggested that a daily dose of more than 54mg could decrease the endometrial thickness for 0.26mm (10 trials, 984subjects; SMD:-0.26; 95%CI:-0.45, −0.07; P=0.007). Furthermore, isoflavone supplementation significantly decrease the endometrial thickness for 0.23mm in North American studies (7 trials, 726 subjects; SMD:-0.23; 95%CI:-0.44, −0.01; P=0.04), but it suggested an increase for 0.23mm in Asian studies (3 trials, 224 subjects; SMD: 0.23; 95%CI:-0.04, 0.50; P=0.10). CONCLUSION: Oral isoflavone supplementation might have different effects in different populations and at different daily doses. Multiple-centre, larger, and long-term trials are deserved to further evaluate its effect.
format Online
Article
Text
id pubmed-4951218
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-49512182016-07-21 Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials Liu, Jie Yuan, Feixiang Gao, Jian Shan, Boer Ren, Yulan Wang, Huaying Gao, Ying Oncotarget Research Paper: Gerotarget (Focus on Aging) BACKGROUND: Isoflavone from soy and other plants modulate hormonal effects in women, and the hormone disorder might result in different caners including endometrial cancer. However, it's effect on the risk of endometrial cancer is still inconclusive. We aimed to assess the effects of isoflavone on endometrial thickness, a risk factor of endometrial cancer in peri- and post-menopausal women. METHODS: A meta-analysis of randomized controlled trials was conducted to evaluate the effect of oral isoflavone supplementation on endometrial thickness in peri- and post-menopausal women. Electronic searches were performed on the PubMed, Embase, the Cochrane Library, web of science, CINAHL, and WHO ICTRP to August 1(st), 2015. Reviews and reference lists of relevant articles were also searched to identify more studies. Summary estimates of standard mean differences (SMD's) and 95%CIs were obtained with random-effects models. Heterogeneity was evaluated with meta-regression and stratified analyses. RESULTS: A total of 23 trials were included in the current analysis. The overall results did not show significant change of endometrial thickness after oral isoflavone supplementation (23 studies, 2167subjects; SMD:-0.05; 95%CI:-0.23, 0.13; P=0.60). Stratified analysis suggested that a daily dose of more than 54mg could decrease the endometrial thickness for 0.26mm (10 trials, 984subjects; SMD:-0.26; 95%CI:-0.45, −0.07; P=0.007). Furthermore, isoflavone supplementation significantly decrease the endometrial thickness for 0.23mm in North American studies (7 trials, 726 subjects; SMD:-0.23; 95%CI:-0.44, −0.01; P=0.04), but it suggested an increase for 0.23mm in Asian studies (3 trials, 224 subjects; SMD: 0.23; 95%CI:-0.04, 0.50; P=0.10). CONCLUSION: Oral isoflavone supplementation might have different effects in different populations and at different daily doses. Multiple-centre, larger, and long-term trials are deserved to further evaluate its effect. Impact Journals LLC 2016-03-07 /pmc/articles/PMC4951218/ /pubmed/26967050 http://dx.doi.org/10.18632/oncotarget.7959 Text en Copyright: © 2016 Liu et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper: Gerotarget (Focus on Aging)
Liu, Jie
Yuan, Feixiang
Gao, Jian
Shan, Boer
Ren, Yulan
Wang, Huaying
Gao, Ying
Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title_full Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title_fullStr Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title_full_unstemmed Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title_short Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
title_sort oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials
topic Research Paper: Gerotarget (Focus on Aging)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951218/
https://www.ncbi.nlm.nih.gov/pubmed/26967050
http://dx.doi.org/10.18632/oncotarget.7959
work_keys_str_mv AT liujie oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT yuanfeixiang oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT gaojian oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT shanboer oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT renyulan oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT wanghuaying oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials
AT gaoying oralisoflavonesupplementationonendometrialthicknessametaanalysisofrandomizedplacebocontrolledtrials